Wintrust Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-823
| Closed | -$78K | – | 493 |
|
|
2024
Q3 | $78K | Sell |
823
-7,412
| -90% | -$702K | 0.06% | 246 |
|
|
2024
Q2 | $753K | Hold |
8,235
| – | – | 0.06% | 232 |
|
|
2024
Q1 | $747K | Hold |
8,235
| – | – | 0.07% | 229 |
|
|
2023
Q4 | $670K | Sell |
8,235
-50
| -0.6% | -$4.07K | 0.06% | 232 |
|
|
2023
Q3 | $662K | Hold |
8,285
| – | – | 0.07% | 233 |
|
|
2023
Q2 | $653K | Buy |
+8,285
| New | +$653K | 0.07% | 229 |
|
|
2022
Q1 | – | Sell |
-11,455
| Closed | -$882K | – | 434 |
|
|
2021
Q4 | $882K | Sell |
11,455
-365
| -3% | -$28.1K | 0.08% | 186 |
|
|
2021
Q3 | $861K | Sell |
11,820
-200
| -2% | -$14.6K | 0.12% | 134 |
|
|
2021
Q2 | $878K | Buy |
12,020
+400
| +3% | +$29.2K | 0.09% | 177 |
|
|
2021
Q1 | $802K | Buy |
+11,620
| New | +$802K | 0.08% | 194 |
|
|
2020
Q4 | – | Sell |
-10,070
| Closed | -$626K | – | 310 |
|
|
2020
Q3 | $626K | Hold |
10,070
| – | – | 0.09% | 167 |
|
|
2020
Q2 | $627K | Sell |
10,070
-1,550
| -13% | -$96.5K | 0.09% | 161 |
|
|
2020
Q1 | $632K | Buy |
11,620
+1,200
| +12% | +$65.3K | 0.1% | 141 |
|
|
2019
Q4 | $669K | Sell |
10,420
-450
| -4% | -$28.9K | 0.09% | 165 |
|
|
2019
Q3 | $619K | Buy |
10,870
+50
| +0.5% | +$2.85K | 0.09% | 177 |
|
|
2019
Q2 | $635K | Buy |
10,820
+1,050
| +11% | +$61.6K | 0.1% | 170 |
|
|
2019
Q1 | $593K | Sell |
9,770
-350
| -3% | -$21.2K | 0.1% | 176 |
|
|
2018
Q4 | $554K | Sell |
10,120
-30
| -0.3% | -$1.64K | 0.1% | 169 |
|
|
2018
Q3 | $653K | Hold |
10,150
| – | – | 0.11% | 178 |
|
|
2018
Q2 | $599K | Sell |
10,150
-750
| -7% | -$44.3K | 0.1% | 184 |
|
|
2018
Q1 | $619K | Sell |
10,900
-1,800
| -14% | -$102K | 0.16% | 120 |
|
|
2017
Q4 | $753K | Sell |
12,700
-810
| -6% | -$48K | 0.18% | 124 |
|
|
2017
Q3 | $780K | Buy |
13,510
+7,560
| +127% | +$436K | 0.2% | 116 |
|
|
2017
Q2 | $351K | Buy |
5,950
+100
| +2% | +$5.9K | 0.09% | 211 |
|
|
2017
Q1 | $323K | Buy |
+5,850
| New | +$323K | 0.09% | 218 |
|